المؤلفون: Jayvant Heera, Srinivas Rao Valluri, Silvia Nozza, Hans Jürgen Stellbrink, Geoffrey Mukwaya, Annie F. Fang, Lynn McFadyen, Eric L E Fevre, Charles Craig, Alex R. Rinehart, Michael S. Saag, Manoli Vourvahis, Andrew Clark, Andrew Carr, Carl J. Fichtenbaum

المصدر: AIDS (London, England)

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, medicine.medical_specialty, maraviroc, Sustained Virologic Response, Anti-HIV Agents, Immunology, HIV Infections, darunavir, Emtricitabine, law.invention, Plasma, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Antiretroviral Therapy, Highly Active, Internal medicine, medicine, Humans, Immunology and Allergy, 030212 general & internal medicine, Adverse effect, Darunavir, emtricitabine, Maraviroc, business.industry, treatment-naive, virus diseases, Viral Load, Clinical Science, 030112 virology, tenofovir, Viral Tropism, nucleos(t)ide-sparing regimen, Regimen, Treatment Outcome, Infectious Diseases, chemistry, HIV-1, RNA, Viral, Female, Ritonavir, business, Viral load, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25164f5fd5aa38ddfdccebac35b9bab2
https://doi.org/10.1097/qad.0000000000001058